Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-12

Clinical Trial Update: Clinical Trial of FCN-437c Capsule in Patients With Hepatic Insufficiency [Phase 1]

View source ↗

Summary

A Phase 1 trial of FCN-437c Capsule in patients with hepatic insufficiency has completed, according to the update from Ahon Pharmaceutical; no efficacy or safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FCN-437c Capsule (FCN-437c)

Snippet

Sponsor: Ahon Pharmaceutical Co., Ltd. | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED